Chemotherapy +/- whole-brain irradiation (WBI) for primary CNS lymphoma (PCNSL)-first experience with a randomized trial

Reviewer: Ryan Smith, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 20 de mayo del 2002

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

ASCO: Risks of Whole Brain Radiotx May Outweigh Benefits

Jun 2, 2015

Second study suggests new immunotherapy may benefit patients with glioblastoma

Outcomes Similar With Partial, Whole Breast Irradiation

Aug 27, 2012

Five-year outcomes, patterns of failure similar; excellent three-year outcomes post-recurrence

Hypofractionated Breast Irradiation = Reduced Toxicity

Aug 9, 2015

Two studies show benefits for hypofractionated vs conventionally fractionated whole-breast irradiation